FDA Aims To Resolve OTC Labeling Issues At Three Upcoming Meetings

FDA will meet with over-the-counter drug and cosmetics trade associations as many as three more times to discuss outstanding concerns regarding the OTC labeling final rule.

More from Archive

More from Pink Sheet